Here are just a few highlights of recent regulatory activities worldwide, from
patents approved to designations granted to drugs given the green light for one indication or another
The U.S. National Institutes of Health have awarded grants of more than $28 million total aimed at deciphering the language of how and when
genes are turned on and off
Could a growing interest in rare disease on the part of venture capitalists be to the detriment of
novel discoveries by up-and-coming pharmas and biotechs with regard to diseases that affect large populations of patients?
Treatment of many types of pain
has relied on opioids, which bring their own set of problems. DDNews Managing Editor Lloyd Dunlap explores some of the progress that may mitigate such
problems
DDNews columnist and Features Editor Randall C Willis weighs in on the contentious
issue of vaccination and suggests that both sides of the debate may not have much basis for debate in the truest sense of the word
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.